The Board of Directors of PI Industries Limited approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. Crucially, the Board declared an interim dividend of ₹ 5.00 per share (500%) on equity shares with a face value of Re. 1/- each, payable by March 13, 2026. The record date for the dividend entitlement has been fixed for Monday, February 23, 2026.
Financial Results Announcement
At the meeting held today, February 12, 2026, the Board of Directors of PI Industries Limited approved the Unaudited Standalone and Consolidated Financial Results for the third quarter and the nine months ended December 31, 2025. The Statutory Auditors have issued their respective Limited Review Reports, which are enclosed with the filing.
Interim Dividend Declaration
The Board declared an interim dividend of ₹ 5.00 (Rupees five only) per share. This equates to a 500% dividend on the equity shares having a face value of Re. 1/- each. The payment for this dividend is scheduled to be made to eligible members on or before Friday, March 13, 2026. The Company has fixed Monday, February 23, 2026, as the record date for determining dividend eligibility.
Standalone Performance Highlights (Q3 FY26 vs Q3 FY25)
The Standalone Profit After Tax for the quarter ended December 31, 2025, stood at ₹ 2,816 Million, compared to ₹ 4,238 Million in the corresponding quarter last year. For the nine months ended December 31, 2025, the Profit After Tax was ₹ 12,370 Million, up from ₹ 14,807 Million in the previous corresponding nine-month period.
A significant item noted was an Exceptional Item loss of ₹ 206 Million in both the quarter and nine-month periods, primarily due to the reassessment of employee benefit obligations following revised definitions under new labor codes.
Consolidated Performance Highlights (Q3 FY26 vs Q3 FY25)
On a consolidated basis, the Profit After Tax for the quarter ended December 31, 2025, was ₹ 3,113 Million, against ₹ 3,727 Million reported for Q3 FY25. Total income (I+II) for the quarter was ₹ 14,424 Million.
For the nine months ended December 31, 2025, the Consolidated Profit After Tax reached ₹ 11,206 Million. Notably, the Consolidated results include an Exceptional Item gain of ₹ 1,051 Million related to the write-back of contingent consideration from a previous acquisition.
Segment Reporting Summary
The Group continues to report two segments: Agro Chemicals and Pharma.
- Agro Chemicals: This segment generated a Profit Before Tax of ₹ 2,879 Million for the quarter (Standalone: ₹ 3,655 Million). The segment assets were valued at ₹ 1,19,068 Million as of the balance sheet date.
- Pharma: This segment reported a Profit Before Tax of ₹ 580 Million for the quarter, despite changes in inventory valuation impacting results.
The meeting commenced at 2:00 P.M. (IST) and concluded at 6:30 P.M. (IST).
Source: BSE
